Hilltop BioSciences

Hilltop BioSciences, Inc, co-founded by Amanda Drobnis has exclusively licensed and developed a room temperature, easy to use, regenerative allograft in an injectable or membrane form for a wide array of veterinary indications.  This modernized therapeutic helps heal injuries quickly with minimal scar tissue, reduced inflammation and minimal chance of infection.  With over 7M horses in the US, Hilltop Bio will specifically focus on horses with a future plan of entering the small animal market.  Hilltop Bio is changing the way veterinarians treat injuries with a more effective, faster, easy to use therapy.

www.HilltopBioSciences.com

Back to Companies

Amanda Drobnis
CEO